SCHEMBL3755286

SCHEMBL3755286

CN(C)C(=O)Cc1cccc(-c2cc(-c3c(N4CCOCC4)sc4c3CC(C)(C)CC4=O)ccn2)c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 11/20 0.38
ALDH1A1 P00352 2/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
BUB1 O43683 1/20 0.34
KDM1A O60341 1/20 0.34
HDAC1 Q13547 1/20 0.34
JMJD6 Q6NYC1 1/20 0.34
PIK3CD O00329 2/20 0.33
PIK3CA P42336 2/20 0.33
PIK3CB P42338 2/20 0.33
PIK3CG P48736 2/20 0.33
GABRA1 P14867 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRA3 P34903 2/20 0.33
GABRA2 P47869 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3756166 0.92 AOC3 (0.39) AOC3ALDH1A1MAPTSMN1; SMN2PIK3CD
SCHEMBL3761960 0.92 BUB1 (0.37) AOC3ALDH1A1MAPTSMN1; SMN2BUB1
SCHEMBL3764551 0.90 AOC3 (0.36) AOC3ALDH1A1MAPTSMN1; SMN2BUB1
SCHEMBL3763765 0.89 AOC3 (0.38) AOC3BUB1PIK3CDPIK3CAPIK3CB
SCHEMBL3760227 0.89 LRRK2 (0.40) BUB1PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL3767336 0.89 POLB (0.35) AOC3ALDH1A1MAPTSMN1; SMN2BUB1
SCHEMBL3759263 0.89 AOC3 (0.42) AOC3BUB1
SCHEMBL3762316 0.89 LRRK2 (0.41) ALDH1A1SMN1; SMN2BUB1KDM1AHDAC1
SCHEMBL3765767 0.88 PIK3CA (0.36) AOC3ALDH1A1MAPTSMN1; SMN2BUB1
SCHEMBL3759987 0.88 BUB1 (0.36) AOC3BUB1KDM1AHDAC1PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA AOC3 4160/4885ALDH1A1 3061/4885MAPT 790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.